Recon: Zimmer to acquire robotics firm Monogram for $177M; WHO adds Gilead’s biannual HIV shot to PrEP guidelines

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States